LAS VEGAS, March 8, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce it has received a price approval from the Greek Ministry of Development for AMPHOCIL. This represents a major achievement in that Samaritan was able to obtain a price increase reaching the level of 94%, which is the second highest price increase granted by the Ministry.
